Jean‐Pierre Sommadossi

AT-527, a Double Prodrug of a Guanosine Nucleotide Analog, Is a Potent Inhibitor of SARS-CoV-2 <i>In Vitro</i> and a Promising Oral Antiviral for Treatment of COVID-19

Steven S. Good, Jonna B. Westover, Kie Hoon Jung et al. · Antimicrobial Agents and Chemotherapy · 2021 · 131 citations · Full text

Antiviral Effect and Pharmacokinetic Interaction between Nevirapine and Indinavir in Persons Infected with Human Immunodeficiency Virus Type 1

Robert L. Murphy, Jean‐Pierre Sommadossi, Michael Lamson et al. · The Journal of Infectious Diseases · 1999 · 118 citations

Clinical pharmacokinetics of 3′-azido-3′-deoxythymidine (zidovudine) and catabolites with formation of a toxic catabolite, 3′-amino-3′-deoxythymidine

M. Patrick Stagg, E M Cretton, Lauren B. Kidd et al. · Clinical Pharmacology & Therapeutics · 1992 · 93 citations

Unchanged Drug, Molecular Pharmacology, Pharmacological Study +13

Plasma population pharmacokinetics and penetration into cerebrospinal fluid of indinavir in combination with zidovudine and lamivudine in HIV-1-infected patients

Xiaojian Zhou, Diane V. Havlir, Douglas D. Richman et al. · AIDS · 2000 · 49 citations

Lamivudine in combination with zidovudine, stavudine, or didanosine in patients with HIV-1 infection. A randomized, double-blind, placebo-controlled trial

Daniel R. Kuritzkes, Ian C. Marschner, Victoria A. Johnson et al. · AIDS · 1999 · 47 citations